Xian Ya Lin
Directeur/Membre du Conseil chez IVD MEDICAL HOLDING LIMITED
Fortune : 18 M $ au 31/05/2024
Provenance du réseau au premier degré de Xian Ya Lin
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Shanghai Jiao Tong University
200
| College/University | Other Consumer Services | 200 |
Fudan University
149
| College/University | Other Consumer Services | 149 |
| Public Company | Medical Distributors | 13 | |
Dacheng Medical Equipments Shanghai Co. Ltd.
2
| Private Company | 2 | |
Ivd International Ltd.
2
| Private Company | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Xian Ya Lin via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
H-K Acquisition Corp.
 H-K Acquisition Corp. Financial ConglomeratesFinance H-K Acquisition Corp. is a special purpose acquisition company. It was formed for the purpose of conducting an acquisition of, or a business combination with, one or more companies or operating businesses. The company was founded on January 26, 2022 and is headquartered in Hong Kong. | Financial Conglomerates | Chief Operating Officer | |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| BAIDU, INC. | Internet Software/Services | Director/Board Member | |
| University of Hong Kong | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Oklahoma City University | College/University | Masters Business Admin | |
| University of Illinois | College/University | Graduate Degree | |
| University of Michigan | College/University | Masters Business Admin Doctorate Degree | |
| China Europe International Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Hong Kong Polytechnic University | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Shanghai University of Finance & Economics
 Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China. | College/University | Undergraduate Degree Undergraduate Degree | |
Standard Chartered Bank (China) Ltd.
 Standard Chartered Bank (China) Ltd. Major BanksFinance Part of Standard Chartered Plc, Standard Chartered Bank (China) Ltd. is a national bank. The company is based in Shanghai, China. The Chinese company was founded in 2007. Xiao Lei Zhang has been the CEO of the company since 1994. | Major Banks | Corporate Officer/Principal Director of Finance/CFO | |
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| East China University of Science & Technology | College/University | Undergraduate Degree | |
The Chinese Institute of Certified Public Accountants
 The Chinese Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The Chinese Institute of Certified Public Accountants operates as an accounting organization. The private company is based in Beijing, China. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Association of Chartered Certified Accountants (Hong Kong) | Corporate Officer/Principal Corporate Officer/Principal | ||
| The Second Military Medical University | College/University | Undergraduate Degree | |
| HAITONG UNITRUST INTERNATIONAL FINANCIAL LEASING CO.,LTD. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Corporate Officer/Principal | |
| Digital Images Diagnostic (China) Ltd. | Director/Board Member Director/Board Member | ||
Vastec Medical Co., Ltd.
 Vastec Medical Co., Ltd. Medical DistributorsDistribution Services Vastec Medical Co., Ltd. develops, sells, and operates clinical testing equipment. It also offers after-sales services. Its products include immunoassay systems, blood gas and critical care systems, microbial analysis systems, rapid blood sedimentation analysers, blood cell morphology analysis systems, and urine analysis systems. The company was founded on August 31, 1993 and is headquartered in Hong Kong. | Medical Distributors | Director/Board Member Founder Founder | |
| School of Economics | College/University | Doctorate Degree | |
Shanghai Lantu Information Technology Co., Ltd.
 Shanghai Lantu Information Technology Co., Ltd. Internet Software/ServicesTechnology Services Shanghai Lantu Information Technology Co., Ltd. is a company based in Shanghai, CN. Additionally, on December 11, 2020, Shanghai Lantu Information Technology Co. was acquired by Shanghai Xirang Information Technology Co., Ltd. and has subsidiaries in China. However, it is known that the Chinese company was founded in 2011 by Min Chen, Xian Xu. | Internet Software/Services | Corporate Officer/Principal | |
WuXi AppTec (Shanghai) Co. Ltd.
 WuXi AppTec (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of WuXi AppTec Co., Ltd., WuXi AppTec (Shanghai) Co. Ltd. develops and manufactures pharmaceuticals. The company is based in Shanghai, China. | Pharmaceuticals: Major | Chief Investment Officer | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
| Textile Import & Export Corp. | Corporate Officer/Principal | ||
Max Giant Capital Ltd.
 Max Giant Capital Ltd. Investment ManagersFinance Max Giant Capital Ltd(Max Giant Capital) is a private equity firm founded in 2014 by Katherine Tsang, King-Suen Tsang and Shue Ngar Wong. The firm is headquartered in Hong Kong. | Investment Managers | Founder | |
| Max Giant Ltd. | Director/Board Member | ||
| SUNLANDS TECHNOLOGY GROUP | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Shenzhen Jingtai Technology Co., Ltd.
 Shenzhen Jingtai Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shenzhen Jingtai Technology Co., Ltd. is a company that researches and develops biotechnology products. The company is based in Shenzhen, China. The Chinese company was founded in 2015 by Shu Hao Wen, Jian Ma, Li Peng Lai. Jian Ma has been the CEO since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
| BILIBILI INC. | Packaged Software | Chief Tech/Sci/R&D Officer | |
| IVD China Ltd. | Director/Board Member Director/Board Member | ||
| ZHEJIANG NEW CENTURY HOTEL MANAGEMENT CO., LTD. | Hotels/Resorts/Cruise lines | Director/Board Member | |
| Ivd Medical Equipments Shanghai Co. Ltd. | Director/Board Member Director/Board Member | ||
| Suzhou Diagvita Biotechnology Co. Ltd. | Director/Board Member Director/Board Member | ||
| Vastec Medical Equipment Shanghai Co. Ltd. | Director/Board Member Director/Board Member Director/Board Member | ||
| Instrumentation Laboratory Far East Ltd. | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | ||
| Coulter Electronics Hong Kong Ltd. | Sales & Marketing | ||
| Shanghai Immunology Association | President | ||
| CLARITY MEDICAL GROUP HOLDING LIMITED | Medical/Nursing Services | Director/Board Member | |
| PHOENIX TREE HOLDINGS LIMITED | Internet Software/Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
Taizhou EOC Pharma Co., Ltd.
 Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | Pharmaceuticals: Major | Director/Board Member | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Director/Board Member | |
Wuhan Neurophth Biotechnology Co., Ltd.
 Wuhan Neurophth Biotechnology Co., Ltd. BiotechnologyHealth Technology Wuhan Neurophth Biotechnology Co., Ltd. is a leading in-vivo gene therapy company for ophthalmic diseases based in Wuhan, China. The Chinese company's core product, nr082 (nfs-01), is designed to treat ND4-mediated Leber's hereditary optic neuropathy (ND4-LHON) and has been granted orphan drug designation (ODD) by the FDA and EMA. It is the first Chinese gene therapy new drug that has been granted IND approval for clinical trials by the Chinese National Medical Products Administration (NMPA) and the FDA. The company's pipeline also includes ND1-mediated LHON, autosomal dominant optic atrophy, optic nerve protection, vascular retinopathy, and other preclinical candidates. The company was founded in 2016 by Bin Li, Su Xiao, Dabo Cai, and Bin Li has been the CEO since then. | Biotechnology | Director/Board Member | |
| DINGDONG (CAYMAN) LIMITED | Internet Retail | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Biotechnology | Director/Board Member | |
| HK ACQUISITION CORPORATION | Financial Conglomerates | Chief Operating Officer | |
| Million Win Corp. Ltd. | Director/Board Member | ||
| East China Normal University | College/University | Undergraduate Degree Undergraduate Degree | |
| JIANGXI BANK CO., LTD. | Major Banks | Director/Board Member |
Statistiques
Internationale
| Chine | 28 |
| Hong Kong | 15 |
| Etats-Unis | 7 |
| Îles Cayman | 3 |
| Royaume-Uni | 2 |
Sectorielle
| Consumer Services | 14 |
| Commercial Services | 8 |
| Health Technology | 7 |
| Finance | 6 |
| Technology Services | 5 |
Opérationnelle
| Director/Board Member | 241 |
| Corporate Officer/Principal | 102 |
| Undergraduate Degree | 85 |
| Independent Dir/Board Member | 75 |
| Graduate Degree | 47 |
Relations les plus connectées
| Insiders | |
|---|---|
| Siu Ki Lau | 26 |
| Hong Gao Hu | 16 |
| Gui Xiang Ma | 15 |
| Xin Gang Chen | 15 |
| Xiao Yi Ma | 15 |
| Tian Cheng | 14 |
| Er Man Ha | 13 |
| Qi Wei Chen | 12 |
| Kuk Sing Ho | 12 |
| Ping Hu Gui | 11 |
| Wen Zhong Shen | 11 |
| Zhen Sun | 11 |
| Cui Ping Gu | 10 |
| Yi Jun Chen | 10 |
| King Sun Leung | 10 |
- Bourse
- Insiders
- Xian Ya Lin
- Connexions Sociétés
